Display options
Cite
Moukette BM, Castelão-Baptista JP, Ferreira L, et al. . Evid Based Complement Alternat Med. 2021;2021:8858165doi: 10.1155/2021/8858165.
Moukette, B. M., Castelão-Baptista, J. P., Ferreira, L., Silva, A. M., Simões, R. F., Cabral, C., Pieme, C. A., Ngogang, J. Y., Sardão, V. A., & Oliveira, P. J. (2021). . Evidence-based complementary and alternative medicine : eCAM, 20218858165. https://doi.org/10.1155/2021/8858165
Moukette, Bruno M, et al. "." Evidence-based complementary and alternative medicine : eCAM vol. 2021 (2021): 8858165. doi: https://doi.org/10.1155/2021/8858165
Moukette BM, Castelão-Baptista JP, Ferreira L, Silva AM, Simões RF, Cabral C, Pieme CA, Ngogang JY, Sardão VA, Oliveira PJ. . Evid Based Complement Alternat Med. 2021 Feb 22;2021:8858165. doi: 10.1155/2021/8858165. eCollection 2021. PMID: 33688366; PMCID: PMC7920721.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2021 Feb 22;2021:8858165. doi: 10.1155/2021/8858165. eCollection 2021.

[No title available]

Evidence-based complementary and alternative medicine : eCAM

Bruno M Moukette, José P Castelão-Baptista, Luciana Ferreira, Ana M Silva, Rui F Simões, Célia Cabral, Constant A Pieme, Jeanne Y Ngogang, Vilma A Sardão, Paulo J Oliveira

Affiliations

  1. Laboratory of Biochemistry, Department of Biochemistry and Physiological Sciences, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, PO Box 1364, Yaoundé, Cameroon.
  2. CNC-Center for Neuroscience and Cell Biology, University of Coimbra, UC Biotech Building, Lot 8A, Biocant Park, Cantanhede 3060-197, Portugal.
  3. Department of Life Sciences, Faculty of Sciences and Technology, University of Coimbra, Coimbra, Portugal.
  4. University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra 3000-548, Portugal.
  5. University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Clinic Academic Center of Coimbra (CACC), Faculty of Medicine, Coimbra 3000-548, Portugal.

PMID: 33688366 PMCID: PMC7920721 DOI: 10.1155/2021/8858165

Abstract

MATERIALS AND METHODS: Bark extracts of these plants (1 and 25 

RESULTS: The results confirmed that Dox treatment decreased cell mass, mitochondrial membrane potential and metabolic viability, increased mitochondrial superoxide anion, and stimulated caspase-3 and caspase-9-like activities. Pretreatment of the cells with the plant extracts significantly inhibited Dox cytotoxicity, with more significant results at the higher concentration. Measurements of selenium and vitamin C in the extracts revealed higher concentration of both when compared with other Cameroonian spices.

CONCLUSION: Both extracts of

Copyright © 2021 Bruno M. Moukette et al.

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

  1. J Biol Chem. 1961 May;236:1611-3 - PubMed
  2. Biomed Pharmacother. 2017 Jun;90:935-946 - PubMed
  3. J Am Coll Cardiol. 2014 Sep 2;64(9):938-45 - PubMed
  4. J Vis Exp. 2011 May 23;(51): - PubMed
  5. Drug Chem Toxicol. 2016;39(1):87-96 - PubMed
  6. Curr Protoc Toxicol. 2016 May 04;68:2.24.1-2.24.15 - PubMed
  7. Nat Protoc. 2006;1(3):1112-6 - PubMed
  8. Biochim Biophys Acta Mol Basis Dis. 2017 Nov;1863(11):2904-2923 - PubMed
  9. Pharmacol Res. 2018 Jan;127:4-14 - PubMed
  10. Drug Res (Stuttg). 2017 Jun;67(6):358-365 - PubMed
  11. Cardiovasc Toxicol. 2012 Dec;12(4):326-40 - PubMed
  12. Int J Biomed Sci. 2015 Jun;11(2):86-92 - PubMed
  13. Oxid Med Cell Longev. 2016;2016:5724973 - PubMed
  14. Curr Opin Drug Discov Devel. 2010 Jan;13(1):50-65 - PubMed
  15. Food Chem Toxicol. 2016 Nov;97:199-204 - PubMed
  16. Biotechniques. 2011 Feb;50(2):98-115 - PubMed
  17. Life Sci. 2017 Jul 1;180:160-170 - PubMed
  18. Evid Based Complement Alternat Med. 2016;2016:6093783 - PubMed
  19. Chem Biol Drug Des. 2007 Nov;70(5):424-36 - PubMed
  20. Exp Cell Res. 1976 Mar 15;98(2):367-81 - PubMed
  21. Adv Exp Med Biol. 2010;698:36-51 - PubMed
  22. Cancer Chemother Pharmacol. 2009 Sep;64(4):811-27 - PubMed
  23. Chem Biodivers. 2014 Jan;11(1):161-9 - PubMed
  24. Environ Pollut. 2015 Nov;206:619-26 - PubMed
  25. In Vitro Cell Dev Biol Anim. 2011 Feb;47(2):125-31 - PubMed
  26. Food Funct. 2016 Sep 14;7(9):3943-52 - PubMed
  27. BMC Res Notes. 2015 Aug 12;8:344 - PubMed
  28. Biochim Biophys Acta. 2014 Dec;1842(12 Pt A):2468-78 - PubMed
  29. Mitochondrion. 2016 Sep;30:95-104 - PubMed
  30. Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):1904-1911 - PubMed
  31. PLoS One. 2015 Jun 29;10(6):e0129303 - PubMed
  32. J Biomed Opt. 2014 May;19(5):057008 - PubMed
  33. Cardiovasc Toxicol. 2011 Jun;11(2):180-90 - PubMed
  34. Molecules. 2009 Mar 23;14(3):1263-78 - PubMed
  35. Int J Biochem Cell Biol. 2013 Nov;45(11):2379-91 - PubMed
  36. Front Physiol. 2015 Dec 23;6:397 - PubMed
  37. Cell Biol Toxicol. 2009 Jun;25(3):227-43 - PubMed
  38. Anal Biochem. 2018 Jul 1;552:50-59 - PubMed
  39. Biochem J. 2009 Jan 1;417(1):1-13 - PubMed
  40. Basic Clin Pharmacol Toxicol. 2005 Nov;97(5):311-9 - PubMed
  41. Mol Cell Biochem. 2012 Jan;360(1-2):215-24 - PubMed
  42. Biol Res. 2015 Mar 14;48:15 - PubMed
  43. Eur J Biochem. 2000 Sep;267(17):5421-6 - PubMed
  44. Xenobiotica. 2015;45(11):1024-9 - PubMed
  45. Arch Pharm Res. 2017 Jul;40(7):875-883 - PubMed
  46. Life Sci. 2005 Feb 11;76(13):1439-53 - PubMed
  47. Free Radic Res. 2009 Mar;43(3):195-205 - PubMed
  48. Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):243-249 - PubMed
  49. J Mol Cell Cardiol. 2012 Jun;52(6):1213-25 - PubMed
  50. Sci Rep. 2017 Mar 16;7:44735 - PubMed
  51. Toxicology. 2015 Aug 6;334:1-11 - PubMed
  52. Cancer Res. 2007 Sep 15;67(18):8839-46 - PubMed
  53. Life Sci. 2000 May 26;67(1):91-9 - PubMed
  54. J Ethnopharmacol. 2012 May 7;141(1):301-8 - PubMed
  55. Curr Pharm Des. 2011;17(4):357-407 - PubMed
  56. J Agric Food Chem. 2006 Feb 22;54(4):1203-8 - PubMed
  57. Cardiovasc Drugs Ther. 2017 Feb;31(1):63-75 - PubMed
  58. J Cell Physiol. 2017 Jul;232(7):1640-1649 - PubMed
  59. Circ Res. 2020 Mar 27;126(7):926-941 - PubMed

Publication Types